Inherited thrombophilia: A possible cause of in utero vascular thrombosis in children with intestinal atresia

Journal of Pediatric Surgery

Volumn 36, Issue 8, 2001, Pages 1146-1149

  Johnson, Sidney M ^a   Meyers, Rebecka L ^a  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Activated protein C; Factor V Leiden; Factor VII R353Q polymorphism; Intestinal atresia; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; METHYLENETETRAHYDROFOLIC ACID;

CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DNA POLYMORPHISM; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HUMAN; INTESTINE ATRESIA; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

EID: 0034909472     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2001.25733     Document Type: Article

References (27)

1. Experimental intestinal atresia
2. Congenital intestinal atresia: Observations on its origins
3. Prenatal cocaine exposure and fetal vascular disruption
4. Activated protein C resistance in a neonate with venous thrombosis
5. Benefits and risks of oral contraceptives
6. Fetal carriers of the factor V leiden mutation are prone to miscarriage and placental infarction
7. Update on genetic risk factors for thrombosis and atherosclerotic vascular disease
8. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study
9. Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis
10. The mechanism of inactivation of human factor V and human factor Va by activated protein C
11. Laboratory evaluation of hypercoagulable states
12. Activated protein C resistance: Molecular mechanisms
13. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism
14. Anticoagulant protein C pathway defective in majority of thrombophilic patients
15. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism
16. Increased frequency of genetic thrombophilia in women with complications of pregnancy
17. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives
18. Activated protein C sensitivity ratio in pregnant women at delivery
19. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction
20. Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality
21. Genetic polymorphisms of factor VII are not associated with arterial thrombosis
22. Factor VII polymorphisms in populations with different risks of cardiovascular disease
23. Factor VII R 353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls
24. Clinical relevance of polymorphic markers of arterial thrombosis
25. The association of dietary fat and fiber with coagulation factor VII in the elderly: The Rotterdam study
26. Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: Relationship with dyslipidaemia, inflammation, and factor VII genotype